1. 09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models. (21st September 2022) Authors: Strzalkowski, TJ; Cadilha, BL; Dalloul, I; Manske, K; Endres, S; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma. (21st September 2022) Authors: Benmebarek, M; Märkl, F; Keyl, J; Cadilha, B; Geiger, M; Karches, C; Obeck, H; Schwerdtfeger, M; Briukhovetska, D; Jobst, J; Müller, PJ; Seifert, M; Grünmeier, R; Thomas, M; Marr, C; Levesque, M; Heppt, M; Endres, S; Klein, C; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Issue 9 (29th March 2007) Authors: Bauer, C; Bauernfeind, F; Sterzik, A; Orban, M; Schnurr, M; Lehr, H A; Endres, S; Eigler, A; Dauer, M Journal: Gut Issue: Volume 56:Issue 9(2007) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fish oil and ischaemic heart disease. Issue 3 (September 1993) Authors: Kristensen, S D; De Caterina, R; Schmidt, E B; Endres, S Journal: Heart Issue: Volume 70:Issue 3(1993) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Implementation of a clinical trial recruitment support system based on fast healthcare interoperability resources (FHIR) in a cardiology department. (3rd October 2022) Authors: Scherer, C; Endres, S; Orban, M; Kaeaeb, S; Massberg, S; Winter, A; Loebe, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Implementation of a clinical trial recruitment support system based on fast healthcare interoperability resources (FHIR) in a cardiology department. Issue 4 (22nd December 2022) Authors: Scherer, C; Endres, S; Orban, M; Kaeaeb, S; Massberg, S; Winter, A; Loebe, M Journal: European heart journal Issue: Volume 3:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. L4 Synthetic agonistic receptor-activating BiTEs – a modular platform for the efficient targeting of acute myeloid leukemia. (1st October 2020) Authors: Benmebarek, M; Cadilha, BL; Hermann, M; Lesch, S; Augsburger, C; Brauchle, B; Stoiber, S; Darwich, A; Rataj, F; Klein, C; Hopfner, K; Subklewe, M; Endres, S; Kobold, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Issue 5 (May 1997) Authors: Hacker, U T; Gomolka, M; Keller, E; Eigler, A; Folwaczny, C; Fricke, H; Albert, E; Loeschke, K; Endres, S Journal: Gut Issue: Volume 40:Issue 5(1997) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O8 Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death. (1st October 2020) Authors: Metzger, P; Bourhis, HT; Stieg, M; Böhmer, D; Endres, S; Düwell, P; König, LM; Schnurr, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P01.04 APEX-mediated biotinylation as a potent tool for evaluation of chemokine-receptor interactions and respective binding inhibitors. (21st September 2022) Authors: Beimert, A; Perleberg, C; Meyer, B; Kühnemuth, B; Schnell, K; Layritz, P; Grün, J; Gärtig, J; Piseddu, I; Bahner, K; Endres, S; Anz, D Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗